« Return to News | R&D Trends

Royal Philips, GRMC sign 15-year alliance

Wednesday, July 3, 2013 11:00 AM

Royal Philips and Georgia Regents Medical Center (GRMC), Georgia’s public academic health center, have announced a 15-year alliance to enable patient-centered approaches to care and to create a business model that addresses current and future clinical, operational and equipment needs of GRMC sites.

Philips will provide GRMC with a range of consulting services, advanced medical technologies, operational performance and planning and maintenance services with pre-determined monthly operational costs.

The $300 million agreement will support the Georgia Regents Medical Center, Children’s Hospital of Georgia, Georgia Regents University Cancer Center and outpatient clinics. The companies will work to deliver faster, more effective and cost-efficient care from diagnostics to therapeutics and inpatient and outpatient clinical services. The alliance will impact all care areas, including radiology, cardiology, neurology, oncology and pediatrics and enhance medical research and clinical technology R&D initiatives for care delivery innovation.

The agreement encompasses Philips imaging systems, patient monitoring and clinical informatics solutions, as well as lighting and consumer products. Philips will also furnish GRMC access to new equipment as well as educational resources.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.